Let’s start up with the current stock price of Zymeworks Inc. (ZYME), which is $8.30 to be very precise. The Stock rose vividly during the last session to $8.61 after opening rate of $8.61 while the lowest price it went was recorded $8.02 before closing at $8.63.Recently in News on March 14, 2023, Zymeworks to Present Updated Data on Multiple Product Candidates at the American Association for Cancer Research (AACR) Annual Meeting. Eleven abstracts accepted for poster presentation highlight company’s differentiated antibody drug conjugate, multispecific antibody, and clinical product candidates. You can read further details here
Zymeworks Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $10.80 on 01/19/23, with the lowest value was $4.11 for the same time period, recorded on 09/07/22.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Zymeworks Inc. (ZYME) full year performance was 33.01%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Zymeworks Inc. shares are logging -23.15% during the 52-week period from high price, and 101.95% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.11 and $10.80.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 719666 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Zymeworks Inc. (ZYME) recorded performance in the market was 5.60%, having the revenues showcasing 34.30% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 532.86M, as it employees total of 291 workers.
Analysts verdict on Zymeworks Inc. (ZYME)
During the last month, 8 analysts gave the Zymeworks Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 4 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 8.09, with a change in the price was noted +1.85. In a similar fashion, Zymeworks Inc. posted a movement of +28.68% for the period of last 100 days, recording 1,067,320 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ZYME is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Zymeworks Inc. (ZYME): Technical Analysis
Raw Stochastic average of Zymeworks Inc. in the period of last 50 days is set at 28.37%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.38%. In the last 20 days, the company’s Stochastic %K was 62.30% and its Stochastic %D was recorded 55.99%.
Let’s take a glance in the erstwhile performances of Zymeworks Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 5.60%. Additionally, trading for the stock in the period of the last six months notably improved by 68.36%, alongside a boost of 33.01% for the period of the last 12 months. The shares increased approximately by 2.72% in the 7-day charts and went up by -6.74% in the period of the last 30 days. Common stock shares were driven by 34.30% during last recorded quarter.